Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
Nibrin (T337) Peptide BS1282P
Product NameNibrin (T337) Peptide
Catalog No.BS1282P
ApplicationsBlocking
Swiss-ProtO60934
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide Nibrin (T337). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS1282 Nibrin (T337) pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
Nibrin (T337) Peptide
Applications :
Blocking
Background :
DNA repair proteins are necessary for the maintenance of chromosome integrity and are involved in the elimination of premutagenic lesions from DNA. The DNA repair proteins Rad51 and Rad52 are key components of the double-strand-break repair (DSBR) pathway. Rad51 is essential for mitotic and meiotic recombination, and its mutation in yeast and mammalian cells results in chromosome loss. Overexpression of Rad52 confers resistance to ionizing radiation and induces homologous intrachromosomal recombination. Rad52 is thought to be involved in an early stage of Rad51-mediated recombination. Additional proteins involved in the pathway include Dmc1 and nibrin. Dmc1 is specifically involved in meiotic recombination. Nibrin, which complexes with Mre11 and Rad50, is absent in Nijemegen breakage syndrome (NBS) patients.
Alternative Name :
Cell cycle regulatory protein p95; Nijmegen breakage syndrome protein 1; NBN; NBS; NBS1; P95
Swiss-Prot :
O60934
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide Nibrin (T337). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS1282 Nibrin (T337) pAb.
Blocking peptide available as BS1282PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER